Together with these reports, we found that the level of GM-CSF in BALFs is much lower in the DEX-treated group than that in control mice, suggesting GM-CSF, which functions as a key driver for activating the pro-inflammatory role of macrophages, may be targeted by glucocorticoids in hosts with Pneumocystis infection. This evidence concerns the gene CSF2 and Pneumocystis infectious disease.